cushieblog.com
Sosei Heptares Starts New Clinical Development Program
TOKYO and LONDON, Feb. 20, 2019 /PRNewswire/ — Sosei Group Corporation (“the Company”; TSE: 4565), announces that the first healthy subject has been dosed with a novel small molec…